Biologics

Genedata Biologics is an enterprise platform specifically designed for biotherapeutics R&D, addressing the unique challenges of large-molecule discovery. It provides a structured database that centralizes access to all information along the discovery workflow, enabling organizations to accelerate their R&D processes.

Companies like MorphoSys, Janssen, Celgene, and Aptevo utilize the platform to enhance decision-making by mining data, identifying trends, and implementing machine learning strategies. The platform supports various innovative applications and meets new industry scientific and IT requirements, including novel molecular formats, advanced screening technologies, and data FAIRification.

Key Features and Benefits:

• Centralized data repository for biologics discovery, including screening, molecular biology, and analytics.
• Integration with laboratory instruments and support for diverse R&D processes.
• Facilitates collaboration and data exchange with CROs and partners.
• Supports full process automation, standardization, and integration.
• Flexible architecture to accommodate expanding R&D activities and novel therapeutic modalities.

Genedata Biologics is recognized as the industry standard for biopharmaceutical R&D, offering a scalable and flexible solution that can be quickly implemented. It acts as an organizational memory, structuring and protecting critical data assets, and ensuring accessibility and integrity across global operations.

The platform is praised for its ability to support the full diversity of large-molecule processes, from candidate selection to IND filings and commercialization. It is particularly valued for its unique workflow and registration engine, which enhances the quality and efficiency of antibody discovery and protein production.